指南与共识神经肿瘤

162例单中心生长激素分泌型垂体腺瘤患者采用2010年共识标准手术切除后初始与延迟缓解的结果及预测因素

Surgical Results and Predictors of Initial and Delayed Remission for Growth Hormone-Secreting Pituitary Adenomas Using the 2010 Consensus Criteria in 162 Patients from a Single Center.
指南 / 共识 · World Neurosurg · 2018-11-27

单中心连续纳入2013年1月至2014年12月接受生长激素分泌型垂体腺瘤切除术的185例患者,评估肿瘤特征与手术结局。162例中92例(56.8%)单纯手术后达到缓解;Knosp 0-2级和术后第1天GH水平较低是多因素分析中的独立预测因素,基线及术后3个月IGF-1指数或可分别预测初始与延迟缓解。

要点

  • 162例中92例(56.8%)单纯手术后达到缓解,Knosp 0-2级及术后第1天GH水平较低为独立预测因素。
  • 基线IGF-1指数<2.835预测术后3个月随访初始缓解,阳性预测值95.3%、阴性预测值36.6%(P<0.001)。
  • 术后3个月IGF-1指数<1.485预测后续随访延迟缓解,阳性预测值84.6%、阴性预测值92.3%(P<0.001)。

核心结论

  • Knosp 0-2级较低和术后第1天GH水平较低是手术缓解的独立预测因素,基线IGF-1指数与术后3个月IGF-1指数或可分别预测初始缓解与延迟缓解。

研究设计与样本

  • 单中心研究,连续纳入2013年1月至2014年12月接受生长激素分泌型垂体腺瘤切除术的185例患者,评估肿瘤特征与手术结局。
  • 初始或延迟缓解采用2010年共识标准:未接受辅助治疗的情况下,术后3个月随访时IGF-1恢复正常、口服葡萄糖耐量试验GH<0.4 μg/L和/或随机GH<1.0 μg/L。

主要发现

  • 162例中92例(56.8%)单纯手术后达到缓解。
  • 多因素回归分析显示缓解与Knosp 0-2级较低及术后第1天GH水平较低相关。
  • 基线IGF-1指数<2.835预测术后3个月随访初始缓解,阳性预测值95.3%、阴性预测值36.6%(P<0.001)。
  • 术后3个月IGF-1指数在延迟缓解组显著低于未缓解组。
  • 延迟缓解组侵袭性肿瘤更少(1.23 ± 0.21 vs. 1.77 ± 0.37[9.52% vs. 76.47%];P<0.001)。

关键数值与推荐

  • 初始缓解标准(2010年共识标准):未接受辅助治疗时,术后3个月随访IGF-1恢复正常、口服葡萄糖耐量试验GH<0.4 μg/L和/或随机GH<1.0 μg/L。
  • 基线IGF-1指数<2.835预测初始缓解:阳性预测值95.3%、阴性预测值36.6%(P<0.001)。
  • 术后3个月IGF-1指数<1.485预测延迟缓解:阳性预测值84.6%、阴性预测值92.3%(P<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The factors associated with initial and delayed remission after growth hormone (GH)-secreting pituitary adenoma excision have not been completely elucidated. METHODS: We recruited 185 consecutive patients who had undergone resection of GH-secreting pituitary adenomas from January 2013 to December 2014 and assessed their tumor characteristics and surgical outcomes. The criteria for initial or delayed remission (using the 2010 consensus criteria) were normalized insulin-like growth factor 1 (IGF-1) levels, GH levels <0.4 μg/L with an oral glucose tolerance test, and/or random GH levels <1.0 μg/L at or after the postoperative 3-month (PO3M) follow-up, without adjuvant therapy. RESULTS: Remission was achieved in 92 of 162 patients (56.8%) after surgery alone and was associated with a lower Knosp grade of 0-2 and lower postoperative day 1 GH level on multivariate regression analysis. A baseline IGF-1 index (IGF-1 level/upper limit of normal) of <2.835 predicted for initial remission at the PO3M follow-up (positive predictive value, 95.3%; negative predictive value, 36.6%; P < 0.001). The PO3M IGF-1 index was significantly lower in the delayed remission group than in the nonremission group. Furthermore, the former had had fewer invasive tumors (1.23 ± 0.21 vs. 1.77 ± 0.37 [9.52% vs. 76.47%]; P < 0.001). A PO3M IGF-1 index of <1.485 predicted for delayed remission during subsequent follow-up (positive predictive value, 84.6%; negative predictive value, 92.3%; P < 0.001). CONCLUSIONS: A lower Knosp grade of 0-2 and lower postoperative day 1 GH level were independent predictors of surgical remission. The baseline IGF-1 and PO3M IGF-1 indexes might predict for initial and delayed remission, respectively.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Shen M, Tang Y, Shou X, et al. Surgical Results and Predictors of Initial and Delayed Remission for Growth Hormone-Secreting Pituitary Adenomas Using the 2010 Consensus Criteria in 162 Patients from a Single Center. World Neurosurg. 2018. PMID: 30500578. doi:10.1016/j.wneu.2018.11.179

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。